Ketone body esters of S-beta-hydroxybutyrate and/or S-1,3-butanediol for modifying metabolic function
Compositions and methods for producing elevated blood levels of ketone bodies and modifying metabolic function in a mammal. Compositions include at least one ester of S-beta-hydroxybutyrate and/or a mono- or di-ester of S-1,3-butanediol and at least one ketone body component. The ketone body component includes beta-hydroxybutyrate, acetoacetate, or both. The beta-hydroxybutyrate is R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, or both. When the ketone body component is S-beta-hydroxybutyrate, the 1,3-butanediol is R-1,3-butanediol, S-1,3-butanediol, or both. Compositions may comprise a keto stack of multiple forms of ketone bodies.
1. A composition for increasing ketone body level and modifying metabolic function in a subject, the composition comprising:
at least one ester selected from:
an ester of S-beta-hydroxybutyrate or a non-racemic ester mixture enriched in S-beta-hydroxybutyrate relative to R-beta-hydroxybutyrate; and
an ester of S-1,3-butanediol or a non-racemic ester mixture enriched in S-1,3-butanediol relative to R-1,3-butanediol,
with the proviso that at least one ester in the composition is not an ester of S-1,3-butanediol and S-beta-hydroxybutyrate and is not an ester of S-1,3-butanediol and acetoacetate.
2. The composition as in claim 1 , wherein the composition comprises a mono- or di-ester of S-beta-hydroxybutyrate and 1,3-butanediol, with the proviso that 1,3-butanediol is not S-1,3-butanediol or a racemic mixture of S-1,3-butanediol and R-1,3-butanediol.
3. The composition as in claim 2 , wherein the 1,3-butanediol is R-1,3-butanediol or a non-racemic ester mixture enriched in R-1,3-butanediol relative to S-1,3-butanediol.
4. The composition as in claim 1 , wherein the composition comprises a mono- or di-ester of 1,3-butanediol and a non-racemic beta-hydroxybutyrate enriched in S-beta-hydroxybutyrate relative to R-beta-hydroxybutyrate.
5. The composition as in claim 1 , wherein the composition comprises a mono- or di-ester of non-racemic 1,3-butanediol enriched in S-1,3-butanediol relative to R-1,3-butanediol and at least one ketone body selected from beta-hydroxybutyrate and acetoacetate.
6. The composition as in claim 5 , wherein the at least one ketone body comprises S-beta-hydroxybutyrate or a non-racemic ester mixture enriched in S-beta-hydroxybutyrate relative to R-beta-hydroxybutyrate.
7. The composition as in claim 5 , wherein the at least one ketone body comprises acetoacetate.
8. The composition as in claim 1 , wherein the composition comprises a mono- or di-ester of S-1,3-butanediol and beta-hydroxybutyrate, with the proviso that the beta-hydroxybutyrate is not S-beta-hydroxybutyrate or a racemic mixture of S-beta-hydroxybutyrate and R-beta-hydroxybutyrate.
9. The composition as in claim 8 , wherein the beta-hydroxybutyrate is R-beta-hydroxybutyrate or a non-racemic ester mixture enriched in R-beta-hydroxybutyrate relative to S-beta-hydroxybutyrate.
10. The composition as in claim 1 , wherein the at least one ester or ester mixture comprises a di-ester of S-1,3-butanediol and both beta-hydroxybutyrate and acetoacetate, with the proviso that the beta-hydroxybutyrate is not S-beta-hydroxybutyrate or a racemic mixture of S-beta-hydroxybutyrate and R-beta-hydroxybutyrate.
11. The composition as in claim 1 , further comprising at least one of a ketone body salt or a ketone body acid.
12. The composition as in claim 1 , further comprising a carrier, the carrier comprising a powder, liquid, gel, suspension, tablet, capsule, food product, food additive, beverage, beverage additive, or food supplement.
13. The composition as in claim 1 , further comprising at least one of a short chain fatty acid or a medium chain fatty acid, or a mono-, di- or triglyceride of the at least one of the short chain fatty acid or the medium chain fatty acid.
14. A composition for increasing ketone body level and modifying metabolic function in a subject, the composition comprising:
an ester mixture comprising:
an ester of S-beta-hydroxybutyrate or a non-racemic ester mixture enriched in S-beta-hydroxybutyrate relative to R-beta-hydroxybutyrate; and
an ester of 5-1,3-butanediol or a non-racemic ester mixture enriched in S-1,3-butanediol relative to R-1,3-butanediol,
with the proviso that at least one ester of the composition is not an ester of S-1,3-butanediol and S-beta-hydroxybutyrate and not an ester of S-1,3-butanediol and acetoacetate.
15. The composition as in claim 14 , wherein the ester of S-beta-hydroxybutyrate is not an ester of S-beta-hydroxybutyrate and S-1,3-butanediol or an ester of S-beta-hydroxybutyrate and a racemic mixture of S-1,3-butanediol and R-1,3-butanediol.
16. The composition as in claim 15 , wherein the composition further comprises a mono- or di-ester of S-1,3-butanediol, or a non-racemic ester mixture enriched in S-1,3-butanediol relative to R-1,3-butanediol, and at least one ketone body selected from beta-hydroxybutyrate and acetoacetate.
17. The composition as in claim 16 , wherein the composition comprises a di-ester of 5-1,3-butanediol, or a non-racemic ester mixture enriched in 5-1,3-butanediol relative to R-1,3-butanediol, and beta-hydroxybutyrate.
18. The composition as in claim 16 , wherein the composition comprises a di-ester of 5-1,3-butanediol, or a non-racemic ester mixture enriched in 5-1,3-butanediol relative to R-1,3-butanediol, and acetoacetate.
19. The composition as in claim 16 , wherein the composition comprises a mixed di-ester of S-1,3-butanediol, or a non-racemic ester mixture enriched in S-1,3-butanediol relative to R-1,3-butanediol, and beta-hydroxybutyrate and acetoacetate.
20. A composition for increasing ketone body level and modifying metabolic function in a subject, the composition comprising:
an ester mixture comprising:
an ester of S-beta-hydroxybutyrate or a non-racemic ester mixture enriched in S-beta-hydroxybutyrate relative to R-beta-hydroxybutyrate, which is not an ester of S-beta-hydroxybutyrate and S-1,3-butanediol; and
an ester of S-1,3-butanediol or a non-racemic ester mixture enriched in S-1,3-butanediol relative to R-1,3-butanediol, which is not an ester of S-1,3-butanediol and S-beta-hydroxybutyrate.